Effect of backward and forward walking on lower limb strength, balance, and gait in multiple sclerosis: a randomized feasibility trial - DelMastro HM, Ruiz JA, Simaitis LB, Gromisch ES, Neto LO, Cohen ET, Wong E, Krug RJ, Lo AC.
We examined the feasibility of a BW intervention... (Source: SafetyLit)
Source: SafetyLit - March 20, 2023 Category: International Medicine & Public Health Tags: Egress, Escape, Evacuation, Crowds Source Type: news
Examining the influence of cognition on the relationship between backward walking and falls in persons with multiple sclerosis - Edwards EM, Daugherty AM, Fritz NE.
BACKGROUND: Multiple sclerosis (MS) causes motor, cognitive, and sensory impairments that result in injurious falls. Current fall risk measures in MS (ie, forward walking [FW] speed and balance) are limited in their sensitivity. Backward walking (BW) veloc... (Source: SafetyLit)
Source: SafetyLit - March 20, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Online delivery of the individualized reduction of falls intervention for persons with multiple sclerosis who use a wheelchair or scooter full-time: a pilot study - McArthur AR, Peterson EW, Sosnoff J, Backus D, Yarnot R, Abou L, Kish J, Steinkellner S, Sandhu A, Rice L.
This study examined the preliminary efficacy of a gro... (Source: SafetyLit)
Source: SafetyLit - March 20, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
New four year data for Roche ’s Evrysdi reinforce long-term efficacy and safety profile in some of the most severely affected people with types 2 and 3 spinal muscular atrophy (SMA)
Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decreaseData confirm long-term efficacy and safety profile ofEvrysdi in a broad range of people with Type 2 and non‑ambulant Type 3 SMAMore than 8,500 people —from newborns to the over 60s—have been treated withEvrysdi, which is now approved in more than 90 countries worldwideBasel, 20 March 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data for Evrysdi ® (risdiplam) in a broad range of people aged 2-...
Source: Roche Investor Update - March 20, 2023 Category: Pharmaceuticals Source Type: news
New four year data for Roche ’s Evrysdi reinforce long-term efficacy and safety profile in some of the most severely affected people with types 2 and 3 spinal muscular atrophy (SMA)
Data from pivotal SUNFISH study showed increases in motor function observed during the first year were maintained through the fourth year, while the overall rate of adverse events continued to decreaseData confirm long-term efficacy and safety profile ofEvrysdi in a broad range of people with Type 2 and non‑ambulant Type 3 SMAMore than 8,500 people —from newborns to the over 60s—have been treated withEvrysdi, which is now approved in more than 90 countries worldwideBasel, 20 March 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new long-term data for Evrysdi ® (risdiplam) in a broad range of people aged 2-...
Source: Roche Media News - March 20, 2023 Category: Pharmaceuticals Source Type: news
MS Relapse Rate Not Increased After Fertility Treatments
THURSDAY, March 16, 2023 -- For women with multiple sclerosis (MS), there is no increased relapse rate after fertility treatment (FT), according to a study published online March 15 in Neurology, Neuroimmunology& Neuroinflammation.
Edith L.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2023 Category: Pharmaceuticals Source Type: news
Fertility Treatments Pose No Danger to People With MS
THURSDAY, March 16, 2023 -- Women with multiple sclerosis who want to undergo fertility treatment can do so without worry, according to a new study.
Participants who had MS were no more likely to have a flare-up of the disease after receiving... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - March 16, 2023 Category: General Medicine Source Type: news
No Increased MS Relapses for Women on Fertility Treatment
(MedPage Today) -- Fertility treatment was not associated with an increased risk of relapse in women with multiple sclerosis (MS) or clinically isolated syndrome (CIS), retrospective data showed.
Across 80 cycles, the mean annualized relapse rate... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - March 15, 2023 Category: Endocrinology Source Type: news
Peripheral vestibular system involvement in multiple sclerosis and associations with the disease severity - Ayd ın Cantürk, Mutlu B, Yilmaz O, Bayazıt YA.
INTRODUCTION: Multiple sclerosis (MS) is an autoimmune disease that can affect balance, gait, and improve fall risk. The aim of this study was to investigate peripheral vestibular system involvement in MS and associations with the disease severity. ... (Source: SafetyLit)
Source: SafetyLit - March 15, 2023 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news
Consumer Health: Are you at risk for MS?
MS Awareness Week will be observed March 12 –19, which makes this a good time to learn about who might be at risk of developing this potentially disabling disease of the brain and spinal cord. Multiple sclerosis, or MS, affects nearly 1 million people living in the U.S., according to the National Multiple Sclerosis Society. With MS, the immune system attacks the protective sheath that covers nerve fibers, and causes communication problems between your brain and the rest of… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 15, 2023 Category: Databases & Libraries Source Type: news
Multiple sclerosis patients denied vital drug due to shortage of brain specialists, NHS data shows
Patients with multiple sclerosis (MS) are missing out on vital drugs that can put the disease on pause, because there is a nationwide shortage of specialists able to prescribe them. (Source: the Mail online | Health)
Source: the Mail online | Health - March 4, 2023 Category: Consumer Health News Source Type: news
New Digital Tools Promising in MS New Digital Tools Promising in MS
Next generation wearable devices that measure function with a high degree of precision promise to detect earlier changes in multiple sclerosis and differentiate between different subtypes of MS.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 4, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Digital Tool a Better Disability Measure in MS? Digital Tool a Better Disability Measure in MS?
A digital tool to measure gait, which has been used in trials of Alzheimer ' s and Parkinson ' s disease, shows potential in improving measurement of disability among patients with multiple sclerosis.MDedge News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - March 3, 2023 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news
Cognitive Impairment in Multiple Sclerosis Tied to Diet
(MedPage Today) -- A Mediterranean diet was associated with better cognition in people with multiple sclerosis (MS), preliminary data suggested.
Among 563 MS patients in a clinical cohort, higher adherence to a Mediterranean diet predicted a 20... (Source: MedPage Today Neurology)
Source: MedPage Today Neurology - March 3, 2023 Category: Neurology Source Type: news
Physical Activity a Growing Priority for Patients With MS Physical Activity a Growing Priority for Patients With MS
With mounting research showing that physical activity affects brain volume, fatigue, and other outcomes, researchers are finding ways to have patients with multiple sclerosis be more active.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - March 3, 2023 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
